National Research Corporation (
) will begin trading ex-dividend on February 14, 2013. A cash
dividend payment of $0.31 per share is scheduled to be paid on
March 29, 2013. Shareholders who purchased NRCI stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
represents an -82.39% decrease from the prior quarter.
The previous trading day's last sale of NRCI was $55.25,
representing a -5.12% decrease from the 52 week high of $58.23 and
a 47.53% increase over the 52 week low of $37.45.
NRCI is a part of the Health Care sector, which includes
companies such as Covance Inc. (
) and Incyte Corporation (
). NRCI's current earnings per share, an indicator of a company's
profitability, is $2.1. Zacks Investment Research reports NRCI's
forecasted earnings growth in 2012 as 28.11%, compared to an
industry average of 6%.
For more information on the declaration, record and payment
dates, visit the